Skip to main content

Table 4 Relation between mRECIST and vRECIST methods in assessment of the therapeutic response whether CR, PR, SD or PD

From: Role of multislice computed tomography 3D volumetric analysis in the assessment of the therapeutic response of hepatocellular carcinoma after transarterial chemoembolization

  mRECIST
SD PR PD CR
Count Percentage Count Percentage Count Percentage Count Percentage
vRECIST SD 10 28.6% 1 9.1% 0 .0% 0 .0%
PR 25 71.4% 10 90.9% 0 .0% 0 .0%
PD 0 .0% 0 .0% 1 100.0% 0 .0%
CR 0 .0% 0 .0% 0 .0% 3 100.0%
Measure of agreement Kappa P value
.244 .001